Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Genitourinary System II: Bladder and Urethra01:19

Anatomy of the Genitourinary System II: Bladder and Urethra

3.2K
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
3.2K
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

624
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
624
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.6K
Urinary Bladder01:23

Urinary Bladder

4.6K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of 4 local anesthetic techniques for open radical cystectomy: A prospective, randomized controlled trial.

Urologic oncology·2025
Same author

Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer.

The Journal of clinical investigation·2025
Same author

Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark.

Nature communications·2024
Same author

Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry.

Cancers·2024
Same author

Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?

Urology practice·2023
Same author

The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.

Urologic oncology·2023
Same journal

Physician perspectives on the decision-making process for patients with high-risk early-stage triple-negative breast cancer in a community oncology setting.

Future oncology (London, England)·2026
Same journal

Healthcare resource utilization and economic burden of metastatic pancreatic cancer: a US commercial and Medicare claims analysis.

Future oncology (London, England)·2026
Same journal

Disparities in mortality among HER2-positive breast cancer patients treated with trastuzumab in Chile (2015-2024): real-world evidence from 4,920 cases.

Future oncology (London, England)·2026
Same journal

VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcoma.

Future oncology (London, England)·2026
Same journal

Prognostic but not predictive: the clinical implications of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy.

Future oncology (London, England)·2026
Same journal

Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia.

Future oncology (London, England)·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.3K

Genitourinary small cell malignancies: prostate and bladder.

Kashyap Shatagopam1, Hristos Z Kaimakliotis, Liang Cheng

  • 1Department of Urology, Indiana University School of Medicine, Simon Cancer Center, Indianapolis, IN 46202, USA.

Future Oncology (London, England)
|February 13, 2015
PubMed
Summary
This summary is machine-generated.

Small cell carcinoma, an aggressive cancer, affects lungs, prostate, and bladder. Treatment shifts to chemotherapy and local therapies, improving survival for this malignancy.

Keywords:
bladder cancerchemotherapyprostate cancerradiotherapysmall cell carcinomasurgery

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.3K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.9K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.8K

Area of Science:

  • Oncology
  • Medical Malignancies

Background:

  • Small cell carcinoma is an aggressive cancer with poor prognosis, often diagnosed at advanced stages.
  • While originating in the lung, it can occur in extrapulmonary sites like the prostate and bladder, sharing similar outcomes.

Purpose of the Study:

  • To review the management strategies for small cell carcinoma across different sites.
  • To highlight the evolving treatment paradigm and potential for targeted therapies.

Main Methods:

  • Literature review of small cell carcinoma management.
  • Analysis of treatment shifts from surgery to chemotherapy and local therapies.
  • Examination of outcomes for extrapulmonary small cell carcinoma.

Main Results:

  • Management has shifted from surgery to chemotherapy followed by local therapies, improving survival.
  • Platinum-based chemotherapy combined with surgery/radiation shows significant benefit.
  • Extrapulmonary small cell carcinomas share clinicopathologic similarities with lung counterparts.

Conclusions:

  • Current treatment modalities, including platinum-based chemotherapy and local therapies, offer improved survival for small cell carcinoma.
  • Further molecular research is crucial for developing earlier, targeted therapies.